<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134469</url>
  </required_header>
  <id_info>
    <org_study_id>ProGastro 17</org_study_id>
    <nct_id>NCT03134469</nct_id>
  </id_info>
  <brief_title>Efficacy of Probiotics on Excessive Gas Accumulation</brief_title>
  <official_title>Efficacy of Probiotics on Excessive Gas Accumulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Probi AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Probi AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of probiotics on excessive gas accumulation
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 18, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breath hydrogen</measure>
    <time_frame>4 hours</time_frame>
    <description>The level of breath hydrogen is measured after a challenge with lactulose</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Flatulence</condition>
  <condition>Bloating</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intake of a probiotic capsule once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intake of a placebo capsule once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic supplement</intervention_name>
    <description>Probiotic supplement</description>
    <arm_group_label>Probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo supplement</intervention_name>
    <description>Placebo supplement</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults 18-50 years, at the time of signing the informed consent.

          -  Willing and able to give written informed consent for participating in the study

          -  Willing to comply with all study procedures

        Exclusion Criteria:

          -  Chronic intestinal disease, immunodeficiency disorder or immunosuppressive treatment

          -  Clinically significant frequent constipation or diarrhea at the screening visit as
             judged by the Investigator

          -  Known gluten intolerance, lactose intolerance, milk protein allergy

          -  Vegetarian diet

          -  Intake of antibiotics within four weeks prior to the start of the study

          -  Hypersensitivity to any of the ingredients in the investigational product (IP)

          -  Regular intake of probiotics within four weeks prior to the start of the study

          -  History of any clinically significant disease or disorder which, in the opinion of the
             Investigator, may either put the subject at risk if participating in the study, or
             influence the results or the subjectÂ´s ability to participate in the study

          -  Investigator considers the subject unlikely to comply with study procedures,
             restrictions and requirements.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cornelia Lif Tiberg, MD</last_name>
    <phone>+46 18611 1306</phone>
    <email>cornelia-lif-tiberg@ctc-ab.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lund University</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrika Axling, PhD</last_name>
      <phone>+46 46 222 3853</phone>
      <email>ulrika.axling@med.lu.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CTC Clinical Consultants</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cornelia Lif Tiberg, MD</last_name>
      <phone>+46 18 611 1306</phone>
      <email>cornelia-lif-tiberg@ctc-ab.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Flatulence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

